Pre-Exposure Prophylaxis of HIV-1 Infection research hub

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

This study looks at a new daily tablet (F/TAF) for preventing HIV in men and transgender women who have sex with men and are at high risk. It compares it to an existing prevention tablet (F/TDF) to see how well they work and if they are safe.